HMH CDI's COVID-19 Test Licensed   

HMH CDI's COVID-19 Test Licensed

March 24, 2020

Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is pleased to announce that a rapid test for COVID-19 created by its labs at the Center for Discovery and Innovation (CDI) has been licensed to T2 Biosystems, a Massachusetts-based leader of in-vitro diagnostics.

The wider deployment of the COVID-19 test, already in use in the Hackensack Meridian Health network, will meet a crucial need amid the continuing spread of the novel coronavirus.

“Our scientists at the CDI have given our health network a crucial tool to treat New Jersey patients in real-time,” said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health. “Now their innovation will help others at this time of urgent need.”reported across all 50 states, with more than 400 deaths, according to the latest Centers for Disease Control and Prevention (CDC) figures available this week.

Read More

We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy. Accept All CookiesLearn More
X